33) Gandhi J, Zhang J, Xie Y, Shigematsu H, Soh J, Zhang W, Yamamoto H, Peyton M, Girard L, Lockwood WW, Lam WL, Garcia M, Minna JD, Gazdar AF (2009) Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity
in lung cancer cell lines.
...
In lung cancer cell lines, CBD upregulated ICAM - 1, leading to...
Not exact matches
They found out that TiY is capable of distinguishing TICs from non-TICs
in various human
lung cancer cell lines and patient - derived
lung tumors.
Beyond
lung cancer, TiY is able to target TICs
in 28 types of human
cell lines derived from the central nervous system, melanoma, breast, renal, ovarian, colon, and prostate
cancer.
«Our study results suggest a new drug cocktail that is effective
in both human
lung cancer cell lines and fly models,» says Cagan.
To determine whether endothelial
cells — the
cells that
line the interior surface of blood vessels — directly influence breast
cancer cell growth, they then created unique organotypic models of
lung and bone marrow microvascular niches,
in which endothelial
cells formed blood vessel - like structures
in culture as they would
in the original organ.
In tests on EGFR - dependent
lung cancer cell lines, Tan and colleagues show that the drugs gefitinib and bosutinib «showed additive and synergistic effects.»
$ 1.8 M Supports
Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem
Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways
in the Development of Ovarian
Cancer GMNews.com - March 2, 2016 Differences
in Type of Small Protein may further Elucidate
Lung Cancer Risk
in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate
Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the
Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the
Lung Cancer Ribbon?
Effects of the proteasome inhibitor bortezomib alone and
in combination with chemotherapy
in the A549 non-small-
cell lung cancer cell line.
We screened the coding sequences of 518 protein kinases (approximately 1.3 Mb of DNA per sample) for somatic mutations
in 26 primary
lung neoplasms and seven
lung cancer cell lines.
I wanted to inactivate the gene BRAF (a kinase implicated
in several human
cancers)
in A549
cells (a human
lung cancer cell line), armed only with viruses obtained through Addgene's viral service and the methods sections of scientific articles (gasp).
(a kinase implicated
in several human
cancers)
in A549
cells (a human
lung cancer cell line), armed only with viruses obtained through Addgene's viral service and the methods sections of scientific articles (gasp).
Shapiro GI, Koestner DA, Matranga CB, et al: Flavopiridol induces
cell cycle arrest and p53 - independent apoptosis
in non-small
cell lung cancer cell lines.
Along the same
lines,
in non-small
cell lung cancer (NSCLC), acquired resistance to Gefitinib / Erlotinib kinase inhibitors has also been associated with a secondary mutation of the gatekeeper Thr790 residue of the epidermal growth factor receptor (EGFR).
«The TAILOR study draws out attention to the fact that outcomes are poor
in second -
line treatment of non — small -
cell lung cancer, with our available treatments resulting in median progression - free survivals of two or three months,» said Benjamin Solomon, MBBS, PhD, of Peter MacCallum Cancer Centre in Melb
cancer, with our available treatments resulting
in median progression - free survivals of two or three months,» said Benjamin Solomon, MBBS, PhD, of Peter MacCallum
Cancer Centre in Melb
Cancer Centre
in Melbourne.
This drug is indicated
in combination with Cisplatin (a chemotherapeutic drug) for the first -
line treatment of patients with inoperable, locally advanced, or metastatic non-small
cell lung cancer.